{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:11Z","timestamp":1786119611358,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutic Drug Monitoring"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1097\/00007691-200008000-00016","type":"journal-article","created":{"date-parts":[[2003,4,25]],"date-time":"2003-04-25T09:02:56Z","timestamp":1051261376000},"page":"460-464","source":"Crossref","is-referenced-by-count":36,"title":["Comparison of Topiramate Concentrations in Plasma and Serum by Fluorescence Polarization Immunoassay"],"prefix":"10.1097","volume":"22","author":[{"given":"David J.","family":"Berry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Patsalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20110409","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2165\/00003495-199754050-00009","volume":"54","author":"Langtry","year":"1997","journal-title":"Drugs"},{"key":"R2-16-20110409","first-page":"1029","volume":"34","author":"Nayak","year":"1994","journal-title":"J Clin Pharmacol"},{"key":"R3-16-20110409","first-page":"s336","volume":"11","author":"Wu","year":"1994","journal-title":"Pharm Res"},{"key":"R4-16-20110409","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1528-1157.1996.tb00651.x","volume":"37","author":"Sachdeo","year":"1996","journal-title":"Epilepsia"},{"key":"R5-16-20110409","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/000456329903600102","volume":"36","author":"Patsolos","year":"1999","journal-title":"Ann Clin Biochem"},{"key":"R6-16-20110409","first-page":"S152","volume":"36","author":"Reife","year":"1995","journal-title":"Epilepsia"},{"key":"R7-16-20110409","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0378-4347(00)80608-8","volume":"433","author":"Holland","year":"1988","journal-title":"J Chromatogr"},{"key":"R8-16-20110409","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0731-7085(98)00137-X","volume":"19","author":"Riffitts","year":"1999","journal-title":"J Pharm Biomed Anal"},{"key":"R9-16-20110409","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/j.1528-1157.1995.tb05997.x","volume":"36","author":"Doose","year":"1995","journal-title":"Epilepsia"},{"key":"R10-16-20110409","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007691-200008000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:59:23Z","timestamp":1786042763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200008000-00016"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":10,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1097\/00007691-200008000-00016","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}